Today: 20 March 2026
Browse Category

NYSE:HAL 24 September 2025 - 5 January 2026

Halliburton stock rises nearly 5% premarket as Venezuela oil rebuild talk lifts service names

Halliburton stock rises nearly 5% premarket as Venezuela oil rebuild talk lifts service names

Halliburton shares rose 4.7% to $29.60 in premarket trading Monday after U.S. forces removed Nicolás Maduro in Venezuela, raising expectations for renewed oilfield activity. SLB and Baker Hughes also gained. Oil prices slipped, with Brent at $60.26 a barrel. Halliburton and other service firms did not comment on possible new contracts in Venezuela.
SLB stock jumps nearly 5% as 2026 opens — OPEC+ meeting and earnings in focus

SLB stock jumps nearly 5% as 2026 opens — OPEC+ meeting and earnings in focus

SLB shares jumped 4.74% to $40.20 Friday, leading oilfield-services stocks higher ahead of an OPEC+ meeting Sunday and SLB’s Jan. 23 earnings. Halliburton and Baker Hughes also advanced. SLB last traded at $40.23 after hours. Analysts rate the stock a “strong buy” with a $50.96 target, according to Stock Analysis.
Energy stocks today: Oil’s steep 2025 slide weighs on XLE as OPEC+ meeting nears

Energy stocks today: Oil’s steep 2025 slide weighs on XLE as OPEC+ meeting nears

The S&P 500 energy sector fell 0.52% in the final 2025 session as oil prices posted their steepest annual drop since 2020, with WTI settling at $57.42 a barrel and Brent at $60.85, both down about 19% for the year. EQT Corp slid 1.9%, while oilfield services stocks also declined. Traders are awaiting the Jan. 4 OPEC+ meeting for signals on output policy. U.S. crude inventories dropped by 1.9 million barrels last week.
Energy Stocks Slide Today as Oil Drops Below $60: Exxon, Chevron, Refiners and Oil Services Sink (Dec. 16, 2025 — 1:45 p.m. ET Update)

Energy Stocks Slide Today as Oil Drops Below $60: Exxon, Chevron, Refiners and Oil Services Sink (Dec. 16, 2025 — 1:45 p.m. ET Update)

U.S. energy stocks fell sharply Tuesday as Brent crude dropped below $60 and WTI hit multi-year lows. Major names including Exxon Mobil, Chevron, and Marathon Petroleum lost between 2% and nearly 5% intraday. Traders cited optimism over Russia–Ukraine peace talks and weak China data as key drivers. Energy sector ETFs and oilfield services stocks posted some of the steepest declines.
Halliburton’s Big Comeback? Why Experts Say Oil Services Are ‘Down But Not Out’ in 2025

Halliburton’s Big Comeback? Why Experts Say Oil Services Are ‘Down But Not Out’ in 2025

Rothschild & Co Redburn initiated Halliburton with a Buy rating and $35 target, joining several firms raising price targets after strong Q3 results. Halliburton posted $5.6 billion in Q3 revenue, beating estimates, and is targeting $100 million in quarterly cost cuts. The company is expanding into data center power and automation amid weak U.S. shale spending. Shares trade near $27 as analysts forecast sector recovery by 2027.
Halliburton Stock Rockets on Q3 Earnings – Oil Sector Trends & Analyst Outlook

Halliburton Stock Rockets on Q3 Earnings – Oil Sector Trends & Analyst Outlook

Halliburton shares jumped nearly 10% to $24–$25 on Oct. 21 after Q3 adjusted EPS of $0.58 beat estimates. Revenue reached $5.6 billion, topping forecasts, though net income fell sharply to $18 million. The company declared a $0.17 dividend and spent $250 million on buybacks. New contracts include a VoltaGrid partnership and Petrobras deepwater deals.
NYSE Rollercoaster: Fed Caution Halts Tech Rally, Mega-Deals & Gold Spike in Wild 48 Hours

NYSE Rollercoaster: Fed Caution Halts Tech Rally, Mega-Deals & Gold Spike in Wild 48 Hours

Wall Street’s AI-fueled rally stalled Sept. 23 as the Nasdaq fell 0.95% and S&P 500 dropped 0.6% after Fed Chair Jerome Powell warned on rates and valuations. Tech stocks led declines, with Nvidia down 3% and Oracle off 4%. Gold hit a record near $3,764/oz as investors sought safety. Micron jumped 3% after strong earnings and an upbeat AI outlook.

Stock Market Today

  • Kessler Topaz Meltzer & Check Files Securities Fraud Class Action Against Soleno Therapeutics
    March 20, 2026, 1:23 PM EDT. Kessler Topaz Meltzer & Check, LLP has filed a securities fraud class action lawsuit against Soleno Therapeutics, Inc. (NASDAQ: SLNO) concerning purchases of SLNO stock between March 26 and November 4, 2025. The lawsuit alleges that Soleno made materially false statements and omissions about safety concerns in its Phase 3 clinical trial for diazoxide choline extended-release tablets used to treat hyperphagia linked to Prader-Willi syndrome. The firm claims the company concealed issues relating to excess fluid retention in trial participants. Investors have until May 5, 2026, to seek lead plaintiff status. The complaint is pending in the U.S. District Court for the Northern District of California under case number 3:26-cv-01979. Investors who suffered losses are urged to contact the law firm for legal options at no cost.
Go toTop